MMNFQ (MedMen Enterprises) Cyclically Adjusted Revenue per Share: $0.36 (As of Mar. 2023)


What is MedMen Enterprises Cyclically Adjusted Revenue per Share?

MedMen Enterprises MMNFQ -90.00% Cyclically Adjusted Revenue per Share is $0.36 as of Mar. 2023.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

MedMen Enterprises's adjusted revenue per share for the three months ended in Mar. 2023 was $0.020. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.36 for the trailing ten years ended in Mar. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-06), MedMen Enterprises's current stock price is $1.0E-5. MedMen Enterprises's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2023 was $0.36. MedMen Enterprises's Cyclically Adjusted PS Ratio of today is 0.00.


MedMen Enterprises  (OTCPK:MMNFQ) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

MedMen Enterprises's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.0E-5/0.36
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


MedMen Enterprises Cyclically Adjusted Revenue per Share Related Terms


MedMen Enterprises Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for MedMen Enterprises's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMen Enterprises Cyclically Adjusted Revenue per Share Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.30 0.32 0.35 0.32

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.32 0.34 0.32 0.36

MMNFQ vs ZTS, VTRS, NBIX: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Cyclically Adjusted PS Ratio falls into.



MedMen Enterprises Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MedMen Enterprises's adjusted Revenue per Share data for the three months ended in Mar. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=0.02/301.8360*301.8360
=0.020

Current CPI (Mar. 2023) = 301.8360.

MedMen Enterprises Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201304 0.002 232.531 0.003
201307 0.002 233.596 0.003
201310 0.002 233.546 0.003
201401 0.004 233.916 0.005
201404 0.001 237.072 0.001
201407 0.001 238.250 0.001
201410 0.014 237.433 0.018
201501 0.001 233.707 0.001
201504 0.001 236.599 0.001
201507 0.001 238.654 0.001
201510 0.001 237.838 0.001
201601 0.001 236.916 0.001
201604 0.001 239.261 0.001
201607 0.001 240.628 0.001
201610 0.005 241.729 0.006
201701 0.005 242.839 0.006
201704 0.000 244.524 0.000
201707 0.000 244.786 0.000
201710 -0.002 246.663 -0.002
201801 0.000 247.867 0.000
201804 0.000 250.546 0.000
201809 0.457 252.439 0.546
201812 0.396 251.233 0.476
201903 0.274 254.202 0.325
201906 0.209 256.143 0.246
201909 0.207 256.759 0.243
201912 0.200 256.974 0.235
202003 0.140 258.115 0.164
202006 0.079 257.797 0.092
202009 0.083 260.280 0.096
202012 0.067 260.474 0.078
202103 0.059 264.877 0.067
202106 0.056 271.696 0.062
202109 0.039 274.310 0.043
202112 0.030 278.802 0.032
202203 0.029 287.504 0.030
202206 0.026 296.311 0.026
202209 0.023 296.808 0.023
202212 0.023 296.797 0.023
202303 0.020 301.836 0.020

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.36 mean?
MedMen Enterprises (MMNFQ) has a Cyclically Adjusted Revenue per Share of $0.36 as of Mar. 2023. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on MedMen Enterprises and its competitors.
Is MedMen Enterprises' Cyclically Adjusted Revenue per Share too high?
MedMen Enterprises' current Cyclically Adjusted Revenue per Share is $0.36.
How does MedMen Enterprises' Cyclically Adjusted Revenue per Share compare to ZTS and VTRS?
MedMen Enterprises' Cyclically Adjusted Revenue per Share of $0.36 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on MedMen Enterprises and its competitors. MedMen Enterprises's current Cyclically Adjusted Revenue per Share is $0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMen Enterprises stock overvalued right now?
MedMen Enterprises (MMNFQ) has a current Cyclically Adjusted Revenue per Share of $0.36. The current Cyclically Adjusted Revenue per Share is $0.36. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For MedMen Enterprises (MMNFQ), the current Cyclically Adjusted Revenue per Share is $0.36 as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMen Enterprises Business Description

Address 8740 S Sepulveda Boulevard, Suite 105, Los Angeles, CA, USA, 90045
MedMen Enterprises Inc is a American cannabis company dedicated to improving life with Cannabis for All. With operations across the United States in California, Nevada, Illinois, Arizona, Massachusetts, and New York, the company has MedMen and LuxLyte brands offering cannabis in consumer-preferred product forms for medical and recreational use. It produces and curates the consumer product assortment for retail operations in its local communities, and drives consumer loyalty with service and engaging in-store experience, combined with reward, delivery, and e-commerce programs.